Rosacea study tests smartphone reminders to boost treatment success

NCT ID NCT04275999

Completed Disease control Sponsor: Wake Forest University Health Sciences Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether weekly digital surveys and a skin hydration monitor could help people with rosacea use their ivermectin cream more consistently. Thirty adults with rosacea were given ivermectin and split into groups: some received no extra support, some got weekly digital check-ins, and others used a device to measure skin moisture. The goal was to see if these tools improve adherence and prevent rosacea from coming back.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ivermectin
What this could lead to: If successful, this approach could help rosacea patients stay on their medication and reduce disease flare-ups.
What could go wrong: This is a small, early-phase trial focused on adherence, not on curing rosacea. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ROSACEA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

rosacea

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ROSACEA

Contacts and locations

Locations

Wake Forest Health Sciences Dermatology

Winston-Salem, North Carolina, 27104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.